Quantification of GS-441524 concentration in feline plasma using high performance liquid chromatography with fluorescence detection

References

• Avataneo V, de Nicolò A, Cusato J, Antonucci M, Manca A, Palermiti A, Waitt C, Walimbwa S, Lamorde M, di Perri G, et al. 2020. Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease. J Antimicrob Chemother. 75(7):1772–1777. doi: 10.1093/jac/dkaa152.
   PubMed Web of Science ®Google Scholar
• Alvarez JC, Moine P, Etting I, Annane D, Larabi IA. 2020. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient. Clin Chem Lab Med. 58(9):1461–1468. doi: 10.1515/cclm-2020-0612.
   PubMed Web of Science ®Google Scholar
• Badgujar KC, Ram AH, Zanznay R, Kadam H, Badgujar VC. 2020. Remdesivir for COVID-19: a review of pharmacology, mechanism of action, in-vitro activity and clinical use based on available case studies. J Drug Delivery Ther. 10(4-s):264–270. doi: 10.22270/jddt.v10i4-s.4313.
   Google Scholar
• Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, ACTT-1 Study Group Members., et al. 2020. Remdesivir for the treatment of Covid-19. N Engl J Med. 383(19):1813–1826. doi: 10.1056/NEJMoa2007764.
   PubMed Web of Science ®Google Scholar
• Coggins S, Kimble B, Norris MJ, Thompson FM, Malik R, Govendir M. 2022. Stability of remdesivir and in-vitro formation of GS-441524 using feline hepatic microsomes, blood and plasma. International Society for Companion Animal Infectious Diseases; Glasgow, Scotland.
   Google Scholar
• COVID-19 Treatment Guidelines Panel. 2019. Coronavirus Disease. (COVID-19) Treatment Guidelines. National Institutes of Health. [accessed 2022 Aug 29]. https://www.covid19treatmentguidelines.nih.gov/.
   Google Scholar
• Deb S, Reeves AA, Hopefl R, Bejusca R. 2021. ADME and pharmacokinetic properties of remdesivir: its drug interaction potential. Pharmaceuticals. 14(7):655. doi: 10.3390/ph14070655.
   Web of Science ®Google Scholar
• Dolan JW. 2012. When should an internal standard be used? LCGC North America. 30:474–480.
   Web of Science ®Google Scholar
• Du P, Wang G, Yang S, Li P, Liu L. 2021. Quantitative HPLC-MS/MS determination of Nuc, the active metabolite of remdesivir, and its pharmacokinetics in rat. Anal Bioanal Chem. 413(23):5811–5820. doi: 10.1007/s00216-021-03561-8.
   PubMed Web of Science ®Google Scholar
• ICH Harmonised Guideline. 2022. Bioanalytical method validation and study sample analysis M10. ICH Harmonised Guideline: Geneva, Switzerland.
   Google Scholar
• Habler K, Brügel M, Teupser D, Liebchen U, Scharf C, Schönermarck U, Vogeser M, Paal M. 2021. Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC–MS/MS method in human serum. J Pharm Biomed Anal. 196:113935. doi: 10.1016/j.jpba.2021.113935.
   PubMed Web of Science ®Google Scholar
• Hamdy MM, Abdel Moneim MM, Kamal MF. 2021. Accelerated stability study of the ester prodrug remdesivir: recently FDA-approved Covid-19 antiviral using reversed-phase-HPLC with fluorimetric and diode array detection. Biomed Chromatogr. 35(12):e5212. doi: 10.1002/bmc.5212.
   PubMed Web of Science ®Google Scholar
• Imre S, Tero-Vescan A, Dogaru MT, Kelemen L, Muntean D-L, Curticapean A, Szegedi N, Vari C-E. 2019. With or without internal standard in HPLC bioanalysis. A case studies. J Chromatogr Sci. 57(3):243–248. doi: 10.1093/chromsci/bmy106.
   PubMed Web of Science ®Google Scholar
• Jorgensen SC, Kebriaei R, Dresser LD. 2020. Remdesivir: review of pharmacology, pre-clinical data, and emerging clinical experience for COVID-19. Pharmacotherapy: J Human Pharmacol Drug Therapy. 40(7):659–671. doi: 10.1002/phar.2429.
   Google Scholar
• Kokic G, Hillen HS, Tegunov D, Dienemann C, Seitz F, Schmitzova J, Farnung L, Siewert A, Höbartner C, Cramer P. 2021. Mechanism of SARS-CoV-2 polymerase stalling by remdesivir. Nat Commun. 12(1):279. doi: 10.1038/s41467-020-20542-0.
   PubMed Web of Science ®Google Scholar
• Li Y, Cao L, Li G, Cong F, Li Y, Sun J, Luo Y, Chen G, Li G, Wang P, et al. 2022. Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models. J Med Chem. 65(4):2785–2793. doi: 10.1021/acs.jmedchem.0c01929.
   PubMed Web of Science ®Google Scholar
• Lipka E, Vaccher C. 2015. Quantitative analysis of drugs in biological matrices by HPLC hyphenated to fluorescence detection. Bioanalysis. 7(6):743–762. doi: 10.4155/bio.15.20.
   PubMed Web of Science ®Google Scholar
• Malik R. 2022. Treatment of FIP in cats with subcutaneous remdesivir followed by oral GS-441524 tablets. [accessed 10 October]. https://sockfip.org/wp-content/uploads/2021/11/Remdesivir-Rx-from-Australia.pdf.
   Google Scholar
• Moneim MMA, Kamal MF, Hamdy MM. 2021. Rapid sensitive bioscreening of remdesivir in COVID-19 medication: selective drug determination in the presence of six co-administered therapeutics. Rev Analytical Chem. 40(1):323–333. doi: 10.1515/revac-2021-0141.
   Web of Science ®Google Scholar
• Murphy BG, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C, Liepnieks M, Pedersen NC. 2018. The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol. 219:226–233. doi: 10.1016/j.vetmic.2018.04.026.
   PubMed Web of Science ®Google Scholar
• O’Reilly KJ, Fishman B, Hitchcock LM. 1979. Feline infectious peritonitis: isolation of a coronavirus. Vet Rec. 104(15):348. doi: 10.1136/vr.104.15.348.
   PubMed Web of Science ®Google Scholar
• Pedersen NC. 2009. A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg. 11(4):225–258. doi: 10.1016/j.jfms.2008.09.008.
   PubMed Web of Science ®Google Scholar
• Pedersen NC, Perron M, Bannasch M, Montgomery E, Murakami E, Liepnieks M, Liu H. 2019. Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J Feline Med Surg. 21(4):271–281. doi: 10.1177/1098612X19825701.
   PubMed Web of Science ®Google Scholar
• Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. 2020. Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more. Arch Med Res. 51(6):585–586. doi: 10.1016/j.arcmed.2020.05.001.
   PubMed Web of Science ®Google Scholar
• Taylor. 2022. An update on treatment of FIP in the UK, international society of feline medicine. [accessed 2022 October 10]. https://icatcare.org/app/uploads/2022/05/An-update-on-treatment-of-FIP-in-the-UKv2.pdf.
   Google Scholar
• Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, et al. 2016. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 531(7594):381–385. doi: 10.1038/nature17180.
   PubMed Web of Science ®Google Scholar